Edition:
India

Parabolic Drugs Ltd (PARB.NS)

PARB.NS on National Stock Exchange of India

7.00INR
3:27pm IST
Change (% chg)

Rs-0.10 (-1.41%)
Prev Close
Rs7.10
Open
Rs7.05
Day's High
Rs7.20
Day's Low
Rs7.00
Volume
24,883
Avg. Vol
43,488
52-wk High
Rs10.40
52-wk Low
Rs5.40

Chart for

About

Parabolic Drugs Limited is a holding company. The Company is an integrated, research-based, pharmaceutical manufacturer and exporter, engaged in development and manufacturing of Active Pharmaceutical Ingredients (API) and API intermediates. It is engaged in the manufacture of pharmaceuticals, medicinal chemical and botanical... (more)
No analyst recommendations are available for .

Overall

Beta: 0.84
Market Cap(Mil.): Rs439.43
Shares Outstanding(Mil.): 61.89
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 31.11 16.11
EPS (TTM): -- -- --
ROI: -- 14.34 15.45
ROE: -- 15.64 13.75

BRIEF-India's Parabolic Drugs June-qtr loss narrows

* June quarter loss 126 million rupees versus loss 773.1 million rupees year ago

14 Aug 2017

BRIEF-Parabolic Drugs appoints Ashok Kumar Jindal as CFO

* Says appointed Ashok Kumar Jindal as CFO Source text: (http://bit.ly/2q295Nq) Further company coverage:

10 May 2017

Earnings vs. Estimates

No consensus analysis data available.